Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
The doctor tested me and now Im on a c-pap nightly
Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the covid-19 crisis
Some clinicians prefer this approach for its convenience and the potential for more concentrated telomerase activation
Choi MR, Kouyoumdzian NM, Rukavina Mikusic NL, Kravetz MC, Rosn MI, Rodrguez Fermepin M, Fernndez BE
[PMID: 2821999] PubMed record related to this compound for laboratory literature review